LOXO-101 sulfate
The sulfate salt form of LOXO-101, also called Larotrectinib, which is an ATP-competitive inhibitor of tropomyosin receptor kinases. It was approved by FDA for the treatment of metastatic solid tumors.
Supplier | BOC Sciences |
---|---|
Product # | B0084-474404 |
Pricing | Inquire |
Cas | 1223405-08-0 |
Molecular Weight | 526.51 |
Molecular Formula | C21H24F2N6O6S |
Canonical SMILES | C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F.OS(=O)(=O)O |